Clobetasol propionate foam (Olux-E) - Stiefel Laboratories

Drug Profile

Clobetasol propionate foam (Olux-E) - Stiefel Laboratories

Alternative Names: 0.05% Clobetasol propionate emollient foam - Stiefel; Olux-E; Olux-EF; Primolux

Latest Information Update: 07 Feb 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Stiefel Laboratories
  • Class Anti-inflammatories; Antipsoriatics; Fluorinated steroids; Glucocorticoids
  • Mechanism of Action Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Atopic dermatitis; Psoriasis

Most Recent Events

  • 01 Feb 2013 First generic equivalent available in USA for moderate-to-severe Dermatosis of the scalp
  • 06 Oct 2011 First generic equivalent approved in the US
  • 22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top